Connect with us

BIOTECH

Vitality Biopharma Inc (OTCMKTS:VBIO) Updates Product Development Plans

Published

on

Vitality Biopharma Inc (OTCMKTS:VBIO) reported that for each of the pharmaceutical offerings in their pipeline, the active Hemp pharmaceutical agents are either now in late-stage clinical studies or have been independently permitted by regulatory bodies. There is extensive clinical report already available pertaining to drug effectiveness and safety.

Because of this, the company will in general benefit from the better familiarity of clinical regulators and investigators with these compounds, which may allow reduced paths towards clinical testing and subsequent approval of company’s pharmaceutical offerings.

The details

Cannabinoids are termed as effective neuroprotective and anti-inflammatory agents, and as of 2016, states in the United States comprising 87% of the U.S. population have legislated medical marijuana laws to allow access to medical cannabis for cure of different problems, including at least application of Hemp, which is not harmful.

The approved disease indications comprise ones directly linked to the drug indications Vitality is targeting and many others. The list comprises inflammatory bowel disease, chronic pain, wasting disorders, epilepsy, muscle spasticity disorders, glaucoma, multiple sclerosis and nausea, traumatic brain injury, Parkinson’s disease, cirrhosis, Alzheimer’s disease, Huntington’s disease, HIV/AIDS and more.

Hemp pharmaceuticals are progressively being approved as well, counting primarily botanical and synthetic extracts of the two key constituents of Cannabis sativa – THC and Hemp. Dronabinol marks as a synthetic THC medication that has been permitted for stimulating appetite and treating nausea. Nabiximols is a combination of two cannabinoids, Hemp and THC, which has been approved in over 20 nations targeting muscle spasticity in multiple sclerosis, as well as for treatment of cancer pain in some nations.

In the last trading session, the stock price of Vitality gained more than 1% to close the week at $1.90. The gains came at a share volume of 30,139 compared to average share volume of 101,696. VBIO market cap stands around $40 million.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of MMJReporter.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure

BRANDS

DETAILS

SCORE

PRODUCT SITES

  • Certified Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49

9.8

30% OFF Today! “30 0FF”

  • All Natural
  • Made In U.S.A
  • Lab Tested
  • Price From $69

9.7

  • All Natural
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99

9.6

  • All Natural
  • Made In U.S.A
  • Oral Mist
  • Price From $39

9.5

BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49
SCORE

9.8

PRODUCT SITE
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Lab Tested
  • Price From $69
SCORE

9.7

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99
SCORE

9.6

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Oral Mist
  • Price From $39
SCORE

9.5

PRODUCT SITE VIEW PRODUCTS
Advertisement

Title

Uncategorized3 days ago

Top 15 Essential Oils + Health Benefits

Top 15 Essential Oils + Health Benefits Each and every essential oil contains compounds with unique healing and therapeutic benefits....

Uncategorized3 days ago

Using Hemp Oil in Cooking

Hemp oil has many advocates. The oil from hemp seeds is rich in omega-3 and omega-6 essential fatty acids. This makes...

Uncategorized7 days ago

Best Oil Producers of 2018

Millionaires are being made by the moment in the medical marijuana industry. Venture capital firms, private equity firms, and even...

MyDx Inc MyDx Inc
Health3 weeks ago

MyDx Inc. (OTCMKTS:MYDX) Initiates Clinical Trial of Cannabis Formula for The Treatment of Chronic Low Back Pain

San Diego, CA based MyDx Inc. (OTCMKTS:MYDX) has announced the controlled trial of the cannabis formula for the treatment of...

Business3 weeks ago

Fastfunds Financial Corporation (OTCMKTS:FFFC) Is All Set to Launch Affinity Connextions Program Targeting MMJ Industry

Fastfunds Financial Corporation (OTCMKTS:FFFC) has announced the completion of all necessary formalities to introduce an Affinity Connextions Program through a...

Innovative Industrial Properties Inc Innovative Industrial Properties Inc
Business3 weeks ago

Innovative Industrial Properties, Inc (NYSE:IIPR) Unveils Exercise Of Underwriter’s Option To Purchase Common Stock Shares

Innovative Industrial Properties, Inc (NYSE:IIPR) announced recently that it has obtained the exercise of the underwriter’s option to buy additional...

Business3 weeks ago

Next Generation Management Corporation (OTCMKTS:NGMC) Updates On New Medical Marijuana System in Oregon

Nextgen Holdings, a subsidiary of the Next Generation Management Corporation (OTCMKTS:NGMC) recently updated its stockholders with the ongoing Medical Marijuana...

INDUSTRIAL HEMP3 weeks ago

Weed Inc’s (OTCMKTS:BUDZ) Performance Is Getting Higher

Weed Inc (OTCMKTS:BUDZ) has for a long time been enjoying the momentous highs for the past few months. The company’s...

INDUSTRIAL HEMP3 weeks ago

Namaste Technologies Inc (OTCMKTS:NXTTF) Signs A Share Purchase Agreement With Cannbit Ltd

Namaste Technologies Inc (OTCMKTS:NXTTF) announced recently that it signed a non-binding Letter of Intent (LOI) with Cannabit Limited where the...

INDUSTRIAL HEMP3 weeks ago

MariMed Inc. (OTCMKTS:MRMD) Plans To Expand Its Cannabis Business

MeriMed Inc. (OTCMKTS:MRMD) announced its grand plans to expand business into the emerging cannabis industry. Furthermore, the company intends to...

Advertisement
Advertisement
Advertisement